- Home
- CIVB vs SLP Comparison
CIVB vs SLP Comparison
Compare CIVB & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIVB | SLP |
|---|---|---|
| Founded | 1884 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | EDP Services |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 433.8M | 418.4M |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | CIVB | SLP |
|---|---|---|
| Price | $22.95 | $20.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $25.40 | ★ $28.00 |
| AVG Volume (30 Days) | 84.4K | ★ 325.3K |
| Earning Date | 01-29-2026 | 01-08-2026 |
| Dividend Yield | ★ 2.97% | N/A |
| EPS Growth | ★ 33.31 | N/A |
| EPS | ★ 2.66 | N/A |
| Revenue | ★ $163,095,000.00 | $78,676,000.00 |
| Revenue This Year | $18.06 | $2.64 |
| Revenue Next Year | $11.12 | $6.01 |
| P/E Ratio | $8.61 | ★ N/A |
| Revenue Growth | ★ 11.28 | 5.70 |
| 52 Week Low | $17.47 | $12.39 |
| 52 Week High | $25.59 | $37.67 |
Technical Indicators
Market Signals| Indicator | CIVB | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 51.55 | 65.11 |
| Support Level | $22.27 | $19.50 |
| Resistance Level | $24.00 | $20.60 |
| Average True Range (ATR) | 0.66 | 1.09 |
| MACD | 0.09 | 0.15 |
| Stochastic Oscillator | 54.64 | 98.50 |
Price Performance
Historical ComparisonAbout CIVB Civista Bancshares Inc.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.